Trademark: 85732589
Status Date
Monday, June 6, 2016
Filing Date
Wednesday, September 19, 2012
Published for Opposition
Tuesday, March 5, 2013
Abandoned Date
Monday, June 6, 2016
5 (Based on Intent to Use) Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in dermatology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceuticals, namely, anti-infectives(Based on 44(d) Priority Application) Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in dermatology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceuticals, namely, anti-infectives
Jun 6, 2016
Abandonment Notice Mailed - No Use Statement Filed
Jun 6, 2016
Abandonment - No Use Statement Filed
Oct 23, 2015
Notice Of Approval Of Extension Request E-Mailed
Oct 22, 2015
Extension 5 Granted
Oct 20, 2015
Extension 5 Filed
Oct 20, 2015
Teas Extension Received
May 6, 2015
Notice Of Approval Of Extension Request E-Mailed
May 5, 2015
Extension 4 Granted
Apr 27, 2015
Extension 4 Filed
Apr 27, 2015
Teas Extension Received
Oct 31, 2014
Notice Of Approval Of Extension Request E-Mailed
Oct 30, 2014
Extension 3 Granted
Oct 28, 2014
Extension 3 Filed
Oct 28, 2014
Teas Extension Received
May 9, 2014
Notice Of Approval Of Extension Request E-Mailed
May 8, 2014
Extension 2 Granted
Apr 16, 2014
Extension 2 Filed
May 6, 2014
Case Assigned To Intent To Use Paralegal
Apr 16, 2014
Teas Extension Received
Oct 16, 2013
Notice Of Approval Of Extension Request E-Mailed
Oct 14, 2013
Extension 1 Granted
Oct 14, 2013
Extension 1 Filed
Oct 14, 2013
Teas Extension Received
Apr 30, 2013
Noa E-Mailed - Sou Required From Applicant
Mar 5, 2013
Official Gazette Publication Confirmation E-Mailed
Mar 5, 2013
Published For Opposition
Feb 13, 2013
Notification Of Notice Of Publication E-Mailed
Jan 30, 2013
Law Office Publication Review Completed
Jan 30, 2013
Assigned To Lie
Jan 17, 2013
Approved For Pub - Principal Register
Jan 10, 2013
Teas/Email Correspondence Entered
Jan 10, 2013
Correspondence Received In Law Office
Jan 10, 2013
Teas Response To Suspension Inquiry Received
Dec 21, 2012
Notification Of Letter Of Suspension E-Mailed
Dec 21, 2012
Letter Of Suspension E-Mailed
Dec 21, 2012
Suspension Letter Written
Dec 21, 2012
Assigned To Examiner
Sep 22, 2012
New Application Office Supplied Data Entered In Tram
Sep 22, 2012
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
